老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Phasebio Pharmaceuticals Inc

0.0701
0.0000
成交量：- -
成交额：- -
市值：349.51万
市盈率：-0.03
高：0.0701
开：0.0701
低：0.0701
收：0.0701
52周最高：1.38
52周最低：0.0665
股本：4,985.81万
流通股本：3,441.09万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-2.1189
每股收益(LYR):-2.9844
净资产收益率：-3091.02%
总资产收益率：-106.07%
市净率：-0.03
市盈率(LYR):-0.02

数据加载中...

总览公司新闻资讯公告
2020/03/30

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2020/03/20

重要事件披露

Current report, items 1.01 and 2.03
2020/03/04

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2020/02/11

重要事件披露

Current report, items 8.01 and 9.01
2020/02/04

重要事件披露

Current report, items 8.01 and 9.01
2020/01/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 1.01, 2.01, 3.02, 7.01, and 9.01
2020/01/10

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2020/01/06

SEC问询函

[Cover]Correspondence
2019/11/14

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2019/11/14

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/15

重要事件披露

Current report, items 8.01 and 9.01
2019/09/24

重要事件披露

Current report, items 8.01 and 9.01
2019/08/14

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/14

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/08/13

重要事件披露

Current report, items 2.02 and 9.01
2019/07/29

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
更多